Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma, Head And Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Early research (Phase 1)Study completedNCT02537223
What this trial is testing

Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLocoregionally Advanced
University Health Network, Toronto 9
Not applicableStudy completedNCT05123950
What this trial is testing

Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Bristol-Myers Squibb 304
Testing effectiveness (Phase 2)UnknownNCT05636150
What this trial is testing

A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 48
Not applicableLooking for participantsNCT05808920
What this trial is testing

The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Royal Marsden NHS Foundation Trust 400
Testing effectiveness (Phase 2)Ended earlyNCT00570674
What this trial is testing

Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckBasaloid Squamous Cell CarcinomaUndifferentiated Carcinoma+1 more
Dana-Farber Cancer Institute 29
Large-scale testing (Phase 3)Temporarily pausedNCT01810913
What this trial is testing

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Who this might be right for
Oropharyngeal p16INK4a-Negative Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7+6 more
National Cancer Institute (NCI) 613
Testing effectiveness (Phase 2)Active Not RecruitingNCT07682376
What this trial is testing

Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Harbin Medical University 96
Not applicableStudy completedNCT02879968
What this trial is testing

Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Prince of Songkla University 52
Very early researchWithdrawnNCT04891718
What this trial is testing

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Who this might be right for
Solid Tumour
Presage Biosciences
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07079410
What this trial is testing

Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell CarcinomaResectable Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06728618
What this trial is testing

Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell Carcinoma+1 more
Shanghai Zhongshan Hospital
Large-scale testing (Phase 3)Study completedNCT00162708
What this trial is testing

Very Intense Radiotherapy-chemotherapy Regimen in Advanced HNSCC

Who this might be right for
Oropharynx CancerOral CancerHypopharynx Cancer+1 more
Gustave Roussy, Cancer Campus, Grand Paris 120
Large-scale testing (Phase 3)Study completedNCT00002897
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
European Institute of Oncology 240
Testing effectiveness (Phase 2)Ended earlyNCT02068157
What this trial is testing

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma+4 more
Roswell Park Cancer Institute 3
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)UnknownNCT05737563
What this trial is testing

PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma Abdominal Stage 0
Sun Yat-sen University 380
Large-scale testing (Phase 3)Looking for participantsNCT06138028
What this trial is testing

Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer

Who this might be right for
Metastatic Esophageal Squamous Cell Carcinoma
Qingdao Central Hospital 90
Early research (Phase 1)Study completedNCT00003200
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03224000
What this trial is testing

Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

Who this might be right for
Malignant Neoplasms of Lip Oral Cavity and PharynxOropharyngeal Cancer
M.D. Anderson Cancer Center 90
Next Page
28